Riggs Asset Management’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
Other funds holding SER
BC
WA
LW
KP
Riggs Asset Management's SER Position: Q3 2025 in Review
Riggs Asset Management sold out of Serina Therapeutics (SER) in Q3 2025, closing a stake of 24 shares — an estimated $148 sold.
Riggs Asset Management first reported a position in SER in Q4 2018 and held it in 27 quarters. The position peaked at $4K in Q2 2019. 25 funds tracked by Wall St. Rank hold SER as of Q3 2025.
- Riggs Asset Management reported no remaining Serina Therapeutics position as of Q3 2025 after selling out during the quarter.
- Riggs Asset Management sold 24 Serina Therapeutics shares in Q3 2025, an estimated $148.
- Riggs Asset Management first reported a position in Serina Therapeutics in Q4 2018 and held it in 27 quarters.
- Riggs Asset Management's Serina Therapeutics position peaked at $4K in Q2 2019.
- 25 funds tracked by Wall St. Rank held Serina Therapeutics as of Q3 2025.
Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.